Vericel (VCEL) Preferred Shares Issued (2012 - 2018)
Vericel recorded quarterly Preferred Shares Issued of -$62000.0 in Q3 2018, down 100.09% quarter-over-quarter from $69.1 million in Q2 2018.
Vericel's Preferred Shares Issued history runs 7 years deep, the most recent figure standing at -$62000.0 for Q3 2018.
- In Q3 2018, Preferred Shares Issued changed N/A year-over-year to -$62000.0; the TTM figure through Dec 2019 stood at -$62000.0 (down 100.09% YoY), while the FY2018 annual figure was $70.0 million, changed N/A from the prior year.
- Preferred Shares Issued came in at -$62000.0 for Q3 2018 at Vericel, down from $69.1 million in the prior quarter.
- In the past five years, Preferred Shares Issued ranged from a high of $69.1 million in Q2 2018 to a low of -$469000.0 in Q4 2016.
- A 5-year average of $8.0 million and a median of $94000.0 in 2016 frame the typical range for Preferred Shares Issued.
- Across the five-year window, Preferred Shares Issued plunged 175.53% in 2017 and surged 97430.99% in 2018, its largest moves.
- Vericel's Preferred Shares Issued stood at -$302000.0 in 2014, then soared by 102.65% to $8000.0 in 2015, then sank by 5962.5% to -$469000.0 in 2016, then jumped by 84.86% to -$71000.0 in 2017, then climbed by 12.68% to -$62000.0 in 2018.
- According to Business Quant data, Preferred Shares Issued over the past three periods registered -$62000.0, $69.1 million, and $985000.0 for Q3 2018, Q2 2018, and Q1 2018 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | Vericel | 1.69 Bn | 1.55 Bn | 49.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | -62,000.00 |
| Sep 30, 2018 | -62,000.00 |
| Jun 30, 2018 | 69.11 Mn |
| Jun 30, 2018 | 69.11 Mn |
| Mar 31, 2018 | 985,000.00 |
| Mar 31, 2018 | 985,000.00 |
| Jun 30, 2017 | -71,000.00 |
| Jun 30, 2017 | -71,000.00 |
| Mar 31, 2017 | 71,000.00 |
| Mar 31, 2017 | 71,000.00 |
| Dec 31, 2016 | -469,000.00 |
| Dec 31, 2016 | -469,000.00 |
| Sep 30, 2016 | 117,000.00 |
| Sep 30, 2016 | 117,000.00 |
| Jun 30, 2016 | 94,000.00 |
| Jun 30, 2016 | 94,000.00 |
| Mar 31, 2016 | 258,000.00 |
| Mar 31, 2016 | 258,000.00 |
| Sep 30, 2015 | 8,000.00 |
| Sep 30, 2015 | 8,000.00 |
| Jun 30, 2015 | 3,000.00 |
| Jun 30, 2015 | 3,000.00 |
| Dec 31, 2014 | -302,000.00 |
| Dec 31, 2014 | -302,000.00 |
| Sep 30, 2014 | 41.32 Mn |
| Sep 30, 2014 | 41.32 Mn |
| Jun 30, 2014 | 3.46 Mn |
| Jun 30, 2014 | 3.46 Mn |
| Mar 31, 2014 | 5.46 Mn |
| Mar 31, 2014 | 5.46 Mn |
| Dec 31, 2013 | 1.59 Mn |
| Dec 31, 2013 | 1.59 Mn |
| Sep 30, 2013 | 10.47 Mn |
| Sep 30, 2013 | 10.47 Mn |
| Dec 31, 2012 | -37.27 Mn |
| Dec 31, 2012 | -37.27 Mn |
| Mar 31, 2012 | 37.62 Mn |
| Mar 31, 2012 | 37.62 Mn |